Home Tags Novozymes
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
The current issue discusses both approved and pending bills related to bioscience sector in the Parliament. It features the power-packed interviews with Krishna Mohan Puvvada, Vice President, Novozymes-South Asia; Dr Radha Rangarajan, Director, Central Drug Research Institute; Vikram Thaploo, CEO-Telehealth, Apollo Hospitals; and Vaibhav Tewari, Co-founder & CEO, Portea Medical.
The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large
The partnership will develop new biotech solutions aimed at carbon capture through enzymes
Unveiling its 2025-strategy, Novozymes sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with the ambition to double the company’s revenue by 2030.......................
In an exclusive interview with BioVoice, Krishna Mohan Puvvada – Regional President and Head, Consumer Biosolutions – India, Novozymes shared interesting insights on the latest activities, learnings from covid, future outlook and much more.................